Cameron S. Carter
doi : 10.1038/s41386-020-00944-w
Neuropsychopharmacology volume 46, pages1231–1232 (2021)
Kenneth WenglerBrandon K. AshinoffBret R. Rutherford
doi : 10.1038/s41386-020-00860-z
Neuropsychopharmacology volume 46, pages1233–1239 (2021)
Late-life depression (LLD) is a prevalent and disabling condition in older adults that is often accompanied by slowed processing and gait speed. These symptoms are related to impaired dopamine function and sometimes remedied by levodopa (L-DOPA).
Nicole L. JenniYi Tao Li and Stan B. Floresco
doi : 10.1038/s41386-020-00931-1
Neuropsychopharmacology volume 46, pages1240–1251 (2021)
Efficient decision-making involves weighing the costs and benefits associated with different actions and outcomes to maximize long-term utility. The medial orbitofrontal cortex (mOFC) has been implicated in guiding choice in situations involving reward uncertainty, as inactivation in rats alters choice involving probabilistic rewards.
Mykel A. Robble, Hans S. Schroder, Brian D. Kangas, Stefanie Nickels, Micah Breiger, Ann M. Iturra-Mena, Sarah Perlo, Emilia Cardenas, Andre Der-Avakian, Samuel A. Barnes, Stefan Leutgeb, Victoria B. Risbrough, Gordana Vitaliano, Jack Bergman, William A. Carlezon Jr. & Diego A. Pizzagalli
doi : 10.1038/s41386-021-00998-4
Neuropsychopharmacology volume 46, pages1252–1262 (2021)
Progress towards understanding neural mechanisms in humans relevant to psychiatric conditions has been hindered by a lack of translationally-relevant cognitive tasks for laboratory animals.
Nathaniel G. Harnett, Sanne J. H. van Rooij,Jennifer S. Stevens
doi : 10.1038/s41386-020-00946-8
Neuropsychopharmacology volume 46, pages1263–1271 (2021)
Neurobiological markers of future susceptibility to posttraumatic stress disorder (PTSD) may facilitate identification of vulnerable individuals in the early aftermath of trauma. Variability in resting-state networks (RSNs), patterns of intrinsic functional connectivity across the brain, has previously been linked to PTSD, and may thus be informative of PTSD susceptibility.
Arjun P. Athreya, Tanja Brückl, Elisabeth B. Binder, A. John Rush, Joanna Biernacka, Mark A. Frye, Drew Neavin, Michelle Skime, Ditlev Monrad, Ravishankar K. Iyer, Taryn Mayes, Madhukar Trivedi, Rickey E. Carter, Liewei Wang, Richard M. Weinshilboum, Paul E. Croarkin & William V. Bobo
doi : 10.1038/s41386-020-00943-x
Neuropsychopharmacology volume 46, pages1272–1282 (2021)
Heterogeneity in the clinical presentation of major depressive disorder and response to antidepressants limits clinicians’ ability to accurately predict a specific patient’s eventual response to therapy.
Saskia B. J. Koch, Vanessa A. van Ast, Reinoud Kaldewaij, Mahur M. Hashemi, Wei Zhang, Floris Klumpers & Karin Roelofs
doi : 10.1038/s41386-020-00947-7
Neuropsychopharmacology volume 46, pages1283–1292 (2021)
Early interventions to improve resilience require the identification of objective risk biomarkers for PTSD symptom development. Although altered hippocampal and amygdala volumes are consistently observed in PTSD, it remains currently unknown whether they represent a predisposing vulnerability factor for PTSD symptom development or an acquired consequence of trauma exposure and/or the disorder.
Cory R. Weissman, Itay Hadas, Dengdeng Yu, Brett Jones, Dehan Kong, Benoit H. Mulsant, Daniel M. Blumberger & Zafiris J. Daskalakis
doi : 10.1038/s41386-020-00953-9
Neuropsychopharmacology volume 46, pages1293–1299 (2021)
The effects of common antidepressants on suicidal ideation (SI) is unclear. In the landmark STAR*D trial antidepressants were effective for Major Depressive Disorder (MDD) in early treatment phases, but less effective in later phases.
Dustin Scheinost, Javid Dadashkarimi, Emily S. Finn, Caroline G. Wambach, Caroline MacGillivray, Alexandra L. Roule, Tara A. Niendam, Daniel S. Pine, Melissa A. Brotman, Ellen Leibenluft & Wan-Ling Tseng
doi : 10.1038/s41386-020-00954-8
Neuropsychopharmacology volume 46, pages1300–1306 (2021)
Irritability cuts across many pediatric disorders and is a common presenting complaint in child psychiatry; however, its neural mechanisms remain unclear.
Michael Browning, Amy C. Bilderbeck, Rebecca Dias, Colin T. Dourish, Jonathan Kingslake, Jürgen Deckert, Guy M. Goodwin, Philip Gorwood, Boliang Guo, Catherine J. Harmer, Richard Morriss, Andreas Reif, Henricus G. Ruhe, Anneke van Schaik, Judit Simon, Victor Perez Sola, Dick J. Veltman, Matilde Elices, Anne G. Lever, Andreas Menke, Elisabetta Scanferla, Michael St?blein & Gerard R. Dawson
doi : 10.1038/s41386-021-00981-z
Neuropsychopharmacology volume 46, pages1307–1314 (2021)
Depressed patients often do not respond to the first antidepressant prescribed, resulting in sequential trials of different medications.
Du Lei, Wenbin Li, Maxwell J. Tallman, L. Rodrigo Patino, Robert K. McNamara, Jeffrey R. Strawn, Christina C. Klein, Fabiano G. Nery, David E. Fleck, Kun Qin, Yuan Ai, Jing Yang, Wenjing Zhang, Su Lui, Qiyong Gong, Caleb M. Adler, John A. Sweeney & Melissa P. DelBello
doi : 10.1038/s41386-021-00989-5
Neuropsychopharmacology volume 46, pages1315–1323 (2021)
The goals of the current study were to determine whether topological organization of brain structural networks is altered in youth with bipolar disorder, whether such alterations predict treatment outcomes, and whether they are normalized by treatment. Youth with bipolar disorder were randomized to double-blind treatment with quetiapine or lithium and assessed weekly.
Anne Krogh N?hr, Morten Lindow, Annika Forsingdal, Samuel Demharter, Troels Nielsen, Raimund Buller, Ida Moltke, Morana Vitezic & Anders Albrechtsen
doi : 10.1038/s41386-021-01002-9
Neuropsychopharmacology volume 46, pages1324–1332 (2021)
A better understanding of the biological factors underlying antidepressant treatment in patients with major depressive disorder (MDD) is needed.
E. Leighton Durham, Hee Jung Jeong, Tyler M. Moore, Randolph M. Dupont, Carlos Cardenas-Iniguez, Zaixu Cui, Farrah E. Stone, Marc G. Berman, Benjamin B. Lahey & Antonia N. Kaczkurkin
doi : 10.1038/s41386-020-00952-w
Neuropsychopharmacology volume 46, pages1333–1339 (2021)
Childhood is an important time for the manifestation of psychopathology. Psychopathology is characterized by considerable comorbidity which is mirrored in the underlying neural correlates of psychopathology.
Jay C. Fournier, Michele Bertocci, Cecile D. Ladouceur, Lisa Bonar, Kelly Monk, Halimah Abdul-Waalee, Amelia Versace, Jo?o Paulo Lima Santos, Satish Iyengar, Boris Birmaher & Mary L. Phillips
doi : 10.1038/s41386-021-01001-w
Neuropsychopharmacology volume 46, pages1340–1347 (2021)
Affective disorders (AD, including bipolar disorder, BD, and major depressive disorder) are severe recurrent illnesses.
Rui Yuan, Jordan M. Nechvatal, Christine L. Buckmaster, Sarah Ayash, Karen J. Parker, Alan F. Schatzberg, David M. Lyons & Vinod Menon
doi : 10.1038/s41386-021-00956-0
Neuropsychopharmacology volume 46, pages1348–1356 (2021)
Correlational studies of humans suggest that exposure to early life stress has long-term effects on neural circuits involved in vulnerability and resilience to mental health disorders. Stress-related mental health disorders are more prevalent in women than in men.
Lisa M. St?rkel, Alexander Karabatsiakis, Johanna Hepp, Iris-Tatjana Kolassa, Christian Schmahl & Inga Niedtfeld
doi : 10.1038/s41386-020-00914-2
Neuropsychopharmacology volume 46, pages1357–1363 (2021)
Nonsuicidal self-injury (NSSI) is a prevalent and impairing behavior, affecting individuals with and without additional psychopathology. To shed further light on biological processes that precede and result from NSSI acts, we built on previous cross-sectional evidence suggesting that the endogenous opioid system, and especially ?-endorphin, is involved in the psychopathology of NSSI.
Nirmala Akula, Stefano Marenco, Kory Johnson, Ningping Feng, Kevin Zhu, Anton Schulmann, Winston Corona, Xueying Jiang, Joanna Cross, Bryce England, Aparna Nathan, Sevilla Detera-Wadleigh, Qing Xu, Pavan K. Auluck, Kwangmi An, Robin Kramer, Jose Apud, Brent T. Harris, C. Harker Rhodes, Barbara K. Lipska & Francis J. McMahon
doi : 10.1038/s41386-020-00949-5
Neuropsychopharmacology volume 46, pages1364–1372 (2021)
Despite strong evidence of heritability and growing discovery of genetic markers for major mental illness, little is known about how gene expression in the brain differs across psychiatric diagnoses, or how known genetic risk factors shape these differences.
Jerome A. J. Becker, Lucie P. Pellissier, Yannick Corde, Thibaut Laboute, Audrey Léauté, Jorge Gand?a & Julie Le Merrer
doi : 10.1038/s41386-020-00927-x
Neuropsychopharmacology volume 46, pages1373–1385 (2021)
Understanding the neurobiological underpinnings of abstinence from drugs of abuse is critical to allow better recovery and ensure relapse prevention in addicted subjects.
Sydney Trask, Shane E. Pullins, Nicole C. Ferrara & Fred J. Helmstetter
doi : 10.1038/s41386-021-00959-x
Neuropsychopharmacology volume 46, pages1386–1392 (2021)
The retrosplenial cortex (RSC) is extensively interconnected with the dorsal hippocampus and has several important roles in learning and memory. Recent work has demonstrated that certain types of context-dependent learning are selectively impaired when the posterior, but not the anterior, region of the RSC is damaged, suggesting that the role of the RSC in memory formation may not be uniform along its rostro-caudal axis.
J. Kolla Nathan, R. Mizrahi, K. Karas, C. Wang, R. M. Bagby, S. McMain, A. I. Simpson, P. M. Rusjan, R. Tyndale, S. Houle & I. Boileau
doi : 10.1038/s41386-021-00992-w
Neuropsychopharmacology volume 46, page1393 (2021)
Kenneth L. Davis, René S. Kahn, Antonia New & Andrew Aronson
doi : 10.1038/s41386-021-00999-3
Neuropsychopharmacology volume 46, page1394 (2021)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟